Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold, +117

The Lancet Haematology

Hematological MalignancyOncologyHematologyImmunologyImmune Checkpoint Inhibitor +4

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Saad Z. Usmani, Fredrik Schjesvold, Albert Oriol, +114

The Lancet Haematology

Hematological MalignancyMedicineImmunologyClinical TrialsHematology +5

Cytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming Units

Jeffrey J. Molldrem, Emmanuel Clave, Yin Jiang, +5

Blood

Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Kenneth A. Foon, Michael Boyiadzis, Stephanie R. Land, +10

Journal of Clinical Oncology

Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia

Michael Boyiadzis, Mounzer Agha, Robert L. Redner, +13

Cytotherapy

Hematological MalignancyCell TherapyMedicineAcute Myeloid LeukemiaHematology +9

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Albert Oriol, Alessandra Larocca, +22

Journal of Clinical Oncology

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

Anastasios Raptis, Dimitriοs Mavroudis, AF Suffredini, +5

Bone Marrow Transplantation

TransplantationMarrow TransplantationBone Marrow FailureStem Cell TransplantationHematology +5

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant

Taofeek K. Owonikoko, Mounzer Agha, Ronald Balassanian, +2

Nature Clinical Practice Oncology

Hematological MalignancyCell TherapyAllogeneic Stem-cell TransplantTransplantationGemtuzumab Therapy +6

Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices

Anastasios Raptis, Mei Sheng Duh, Si‐Tien Wang, +7

Transfusion

T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia

DA Mavroudis, E.J. Read, Jeffrey J. Molldrem, +5

Bone Marrow Transplantation

Hematological MalignancyCell TherapyTransplantationMarrow TransplantationAutoimmune Disease +12